advertisement

Stop-smoking

15 September 2010

Smoking: quitting is cost-effective

Investing in smoking cessation treatments saves lives and it may be sound fiscal policy, researchers have said.

Investing in smoking cessation treatments saves lives and it may be sound fiscal policy, researchers have said.

It was funded by a grant from Pfizer Inc, maker of the smoking cessation drug Chantix, known generically as varenicline.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.